Search
for

    Sort by

    Community Join

    660-666 / 666 results

      community Pyrilutamide Phase 3 on its way

      in Treatment  128 upvotes 3 years ago
      Pyrilutamide Phase 3 approved, starting early 2022 with 416 subjects for 24 weeks. Drug potentially better than RU and Breezula, with some users reporting no side effects.